First Time Loading...
Y

YiChang HEC ChangJiang Pharmaceutical Co Ltd
HKEX:1558

Watchlist Manager
YiChang HEC ChangJiang Pharmaceutical Co Ltd
HKEX:1558
Watchlist
Price: 13 HKD -0.46% Market Closed
Updated: May 5, 2024

Wall Street
Price Targets

Price Targets Summary
YiChang HEC ChangJiang Pharmaceutical Co Ltd

Wall Street analysts forecast YiChang HEC ChangJiang Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for YiChang HEC ChangJiang Pharmaceutical Co Ltd is 14.28 HKD with a low forecast of 14.14 HKD and a high forecast of 14.7 HKD.

Lowest
Price Target
14.14 HKD
9% Upside
Average
Price Target
14.28 HKD
10% Upside
Highest
Price Target
14.7 HKD
13% Upside
YiChang HEC ChangJiang Pharmaceutical Co Ltd Competitors:
Price Targets
IOLCP
IOL Chemicals and Pharmaceuticals Ltd
33% Upside
LUPIN
Lupin Ltd
14% Downside
603139
Shaanxi Kanghui Pharmaceutical Co Ltd
44% Upside
BTMD
biote Corp
47% Upside
002365
Qianjiang Yongan Pharmaceutical Co Ltd
129% Upside
CAPLIPOINT
Caplin Point Laboratories Ltd
25% Upside
KLBF
Kalbe Farma Tbk PT
21% Upside
OCUL
Ocular Therapeutix Inc
156% Upside

Revenue
Forecast

Revenue Estimate
YiChang HEC ChangJiang Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for YiChang HEC ChangJiang Pharmaceutical Co Ltd's revenue is 32%. The projected CAGR for the next 3 years is 4%.

32%
Past Growth
4%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
YiChang HEC ChangJiang Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for YiChang HEC ChangJiang Pharmaceutical Co Ltd's operating income is 31%. The projected CAGR for the next 3 years is -8%.

31%
Past Growth
-8%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
YiChang HEC ChangJiang Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for YiChang HEC ChangJiang Pharmaceutical Co Ltd's net income is 29%. The projected CAGR for the next 3 years is -1%.

29%
Past Growth
-1%
Estimated Growth
Estimates Accuracy
5%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is YiChang HEC ChangJiang Pharmaceutical Co Ltd's stock price target?
Price Target
14.28 HKD

According to Wall Street analysts, the average 1-year price target for YiChang HEC ChangJiang Pharmaceutical Co Ltd is 14.28 HKD with a low forecast of 14.14 HKD and a high forecast of 14.7 HKD.

What is YiChang HEC ChangJiang Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
4%

For the last 8 years the compound annual growth rate for YiChang HEC ChangJiang Pharmaceutical Co Ltd's revenue is 32%. The projected CAGR for the next 3 years is 4%.

What is YiChang HEC ChangJiang Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
-8%

For the last 8 years the compound annual growth rate for YiChang HEC ChangJiang Pharmaceutical Co Ltd's operating income is 31%. The projected CAGR for the next 3 years is -8%.

What is YiChang HEC ChangJiang Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
-1%

For the last 8 years the compound annual growth rate for YiChang HEC ChangJiang Pharmaceutical Co Ltd's net income is 29%. The projected CAGR for the next 3 years is -1%.